AsthmaAllergic bronchopulmonary aspergillosis: a US perspectiveVirnig, Christine; Bush, Robert K Author Information William S. Middleton VA Hospital, Madison, Wisconsin, USA Correspondence to Robert K. Bush, MD, William S. Middleton VA Hospital, 2500 Overlook Terrace, Madison, WI 53705, USA Tel: +1 608 263 6174; fax: +1 608 263 3104; e-mail: [email protected] Supported in part by funds from the US Department of Veterans Affairs. Current Opinion in Pulmonary Medicine: January 2007 - Volume 13 - Issue 1 - p 67-71 doi: 10.1097/MCP.0b013e328010c812 Buy Metrics Abstract Purpose of review The present article is an update of allergic bronchopulmonary aspergillosis. Although a rare condition, allergic bronchopulmonary aspergillosis does affect a number of patients with asthma and cystic fibrosis. Prompt recognition and treatment of the disease is critical to improving patient outcomes. Recent findings There is currently much active research being performed in the area of allergic bronchopulmonary aspergillosis. Fascinating insights are being made into the pathophysiology and genetics of the disease. Additionally, research is ongoing on the use of recombinant Aspergillus allergens as an aid to the diagnosis of allergic bronchopulmonary aspergillosis. Summary These new insights into the genetics and pathophysiology of allergic bronchopulmonary aspergillosis and the development of these new diagnostic techniques could ultimately lead to improved patient treatment. These areas form an important basis for further research. © 2007 Lippincott Williams & Wilkins, Inc.